Global Hemostasis Diagnostics Market Future Discussed in Updated Report Published at MarketPublishers.Com
29 Feb 2012 • by Natalie Aster
LONDON – The increasing cost-containment pressures in major industrialized nations, along with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation are likely to radically change the hemostasis diagnostics practice during the next decade.
New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Hemostasis testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the hemostasis testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Updated research report “Future Hemostasis Diagnostics Market Outlook: Emerging Opportunities and Business Expansion Strategies” prepared by Venture Planning Group explores business and technological trends in the world's seven major markets – France, Germany, Italy, Japan, Spain, UK, USA; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles top market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.
Companies mentioned in the report include: Abbott, American Diagnostica, Avocet Medical, Axis-Shield, Beckman Coulter, Becton Dickinson, Bio/Data Corporation, Biosite, Chrono-Log, Corgenix Medical, Diagnostica Stago, Helena Laboratories, HYPEN BioMed, Instrumentation Laboratory, ITC, Nanogen, Roche, Siemens, Sienco, Sysmex, Thermo Fischer, Trinity Biotech, and ZyCare.
Future Hemostasis Diagnostics Market Outlook: Emerging Opportunities and Business Expansion Strategies
Published: February, 2012
Price: US$ 28.700,00
Reports Examining Hemostasis Market Future are Also Available Country-Wise:
- Future US Hemostasis Market Outlook
- Future Japanese Hemostasis Market Outlook
- Future French Hemostasis Market Outlook
- Future UK Hemostasis Market Outlook
- Future Spanish Hemostasis Market Outlook
- Future German Hemostasis Market Outlook
- Future Italian Hemostasis Market Outlook
More new research reports by the publisher can be found at Venture Planning Group page.